AcuraStem
AcuraStem, Inc. is a privately held, patient-based biotechnology company headquartered in Monrovia, California, developing therapeutics for neurodegenerative diseases including sporadic ALS (amyotrophic lateral sclerosis) and frontotemporal dementia (FTD). The company's proprietary iNeuroRx drug-discovery platform builds disease models from induced pluripotent stem cells (iPSC) taken from individual patients, in place of animal models, and pairs them with machine-learning analysis to identify and validate targets. Its lead antisense oligonucleotide candidate, AS-241 (PIKFYVE), is advancing toward first-in-human testing with California Institute for Regenerative Medicine (CIRM) grant support. AcuraStem is a therapeutics developer rather than a software vendor: it publishes no public API, developer portal, SDK, or machine-readable contract of any kind. This profile records that absence with the probe evidence behind it.
AcuraStem is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Therapeutics, Life Sciences, and Drug Discovery.
AcuraStem’s developer surface includes engineering blog and 9 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Commercial 1
Pricing, plans, and the legal terms of use
Company 6
The organization behind the API
Other 1
Properties that don't map to a standard resource type
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.